Arrangements provide increased near-term funding and extend maturity of credit agreement to early 2027- Equity settlement mechanisms also ...

Trinity Biotech (TRIB) entered into a series of agreements with funds managed by Perceptive Advisors designed to enhance the Company’s financial ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...

Trinity Biotech (NASDAQ: TRIB) surged on Tuesday due to a large HIV testing order and balance-sheet restructuring.

An update from Trinity Biotech ( ($TRIB) ) is now available. On December 23, 2025, Trinity Biotech filed a Form 6-K with the U.S. Securities and ...

DUBLIN, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Major U.S. stock indices closed higher Tuesday, with the Dow Jones Industrial Average up 0.16% at 48,442.41, the S&P 500 ...

DUBLIN - Trinity Biotech plc (NASDAQ:TRIB) has secured regulatory clearances in multiple countries for its next-generation high-capacity HbA1c column system for the Premier Hb9210 analyzer, the ...

Investing.com -- Trinity Biotech plc (NASDAQ:TRIB) stock gained 3.7% on Monday following the company’s announcement of regulatory clearances for its next-generation high-capacity HbA1c column system ...

Trinity Biotech ( (TRIB)) just unveiled an update. On December 15, 2025, Trinity Biotech announced that it has secured regulatory clearances in multiple countries and expanded the global rollout of ...